United States · Series B startup

Who invested in Tavotek Biotherapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $35MNov 2021
Investors
2
See who backed them

The rounds

  1. Nov 2021

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tavotek Biotherapeutics

Who invested in Tavotek Biotherapeutics?

Tavotek Biotherapeutics's investors include Oriza Holdings and GF Xinde Investment Management.

How much has Tavotek Biotherapeutics raised?

Tavotek Biotherapeutics has raised $35M across 1 round since 2021.

When did Tavotek Biotherapeutics last raise?

Tavotek Biotherapeutics's most recent round was a Series B of $35M in Nov 2021.

What was Tavotek Biotherapeutics's biggest round?

Its most recent round, $35M in Nov 2021, is also its largest on record.

Who backed Tavotek Biotherapeutics first?

Tavotek Biotherapeutics's first round on record, in Nov 2021, was backed by Oriza Holdings and GF Xinde Investment Management.

What stage is Tavotek Biotherapeutics at?

Tavotek Biotherapeutics's latest named round is a Series B, in Nov 2021.

Where is Tavotek Biotherapeutics based?

Tavotek Biotherapeutics is based in the United States.

Companies like Tavotek Biotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.